Evidence map›Paper›PMID 29321579›Full record

ArticleScientific reports2018

Differentiation potential of Pluripotent Stem Cells correlates to the level of CHD7.

Takako Yamamoto, Chiemi Takenaka, Yusuke Yoda, Yasuhiro Oshima, Kenichi Kagawa, Hiroshi Miyajima, Tetsuji Sasaki, Shin Kawamata

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Generation of xenobiotic free retinofugal assembloids.Frontiers in cell and developmental biology · 2025
    Article
  3. Development of Automated Systems for Cell Therapy.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Takako YamamotoFoundation Biomedical Research and Innovation (FBRI), Research and Development Center for Cell Therapy 2-2 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Chiemi TakenakaFoundation Biomedical Research and Innovation (FBRI), Research and Development Center for Cell Therapy 2-2 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Yusuke YodaFoundation Biomedical Research and Innovation (FBRI), Research and Development Center for Cell Therapy 2-2 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Yasuhiro OshimaTokyo Electron Europe Ltd. Unite G1, Stevenage Bioscience Catalyst Gunnel Wood Road, Stevenage, Hertfordshire, SG1 2FX, United Kingdom.
Kenichi KagawaFoundation Biomedical Research and Innovation (FBRI), Research and Development Center for Cell Therapy 2-2 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Hiroshi MiyajimaProduct Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna Takahagi-shi, Ibaraki, 318-0004, Japan.
Tetsuji SasakiProduct Development Division, Kyokuto Pharmaceutical Industrial Co., Ltd., 3333-26, Aza-Asayama, Kamitezuna Takahagi-shi, Ibaraki, 318-0004, Japan.
Shin KawamataFoundation Biomedical Research and Innovation (FBRI), Research and Development Center for Cell Therapy 2-2 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan. kawamata@fbri.org.
Foundation for Biomedical Research and Innovation · JPStevenage Bioscience Catalyst · GBTokyo Electron (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Embryonic Stem Cells (ESC) possesses two distinct features; self-renewal and the potential to differentiate. Here we show the differentiation potential and growth rate of ESC correlates positively with the expression level of the gene encoding chromodomain helicase DNA binding protein 7 (CHD7). When ESCs are maintained in feeder-free conditions and single cell seeding, ESC KhES-1 having 4520 copies or more of CHD7 in 5 ng total RNA show differentiation potential, but this is lost when the CHD7 copy number is reduced in KhES-1 to less than 696 by alternative culture conditions. Introduction of siCHD7 reduced differentiation potential and growth rate of KhES-1. Interestingly, KhES-1 underwent spontaneous differentiation when mCHD7 was introduced and we could not obtain CHD7-overexpressing ESC in culture. These data suggest that CHD7 drives differentiation, and there is a lower limit for CHD7 to initiate differentiation and an upper limit for CHD7 if maintained in undifferentiated state, and such upper limit varies depending on culture condition. As CHD7 drives cell growth, ESC with the highest permissible CHD7 level in the given culture become dominant in a couple of passages. Thus, we can select differentiation resistance-free cell clones by optimizing the culture system using CHD7 as an index.

Indexed as

Gene Expression Regulation, DevelopmentalCell Culture TechniquesCell DifferentiationCell LineCell ProliferationCells, CulturedDNA-Binding ProteinsDNA HelicasesEmbryonic Stem CellsHumansPluripotent Stem CellsProtein TransportRNA, MessengerRNA, Small InterferingCHD7 protein, humanDNA-Binding ProteinsDNA HelicasesRNA, MessengerRNA, Small Interfering

Identifiers

PMID29321579
PMCPMC5762636
OpenAlexW2781548684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.